Estrella Immunopharma Files 8-K

Ticker: ESLAW · Form: 8-K · Filed: Feb 20, 2025 · CIK: 1844417

Estrella Immunopharma, INC. 8-K Filing Summary
FieldDetail
CompanyEstrella Immunopharma, INC. (ESLAW)
Form Type8-K
Filed DateFeb 20, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: 8-K, corporate-update

Related Tickers: ESLA

TL;DR

Estrella Immunopharma filed an 8-K, check for updates.

AI Summary

Estrella Immunopharma, Inc. filed an 8-K on February 20, 2025, reporting an event on February 19, 2025. The filing indicates a change in the company's structure or operations, as it is listed under 'Other Events' and includes 'Financial Statements and Exhibits'. The company, formerly known as TradeUP Acquisition Corp. until February 4, 2021, is based in Emeryville, California.

Why It Matters

This 8-K filing signals a material event or update for Estrella Immunopharma, Inc., potentially impacting investors' understanding of the company's current status and future prospects.

Risk Assessment

Risk Level: medium — 8-K filings can contain significant information, but without details on the specific 'Other Events', the risk level is moderate.

Key Players & Entities

FAQ

What specific event is being reported under 'Other Events' in this 8-K filing?

The provided text does not specify the exact nature of the 'Other Events' beyond listing it as an item information category.

When did Estrella Immunopharma, Inc. change its name from TradeUP Acquisition Corp.?

The company's name was changed from TradeUP Acquisition Corp. on February 4, 2021.

What is the Commission File Number for Estrella Immunopharma, Inc.?

The Commission File Number for Estrella Immunopharma, Inc. is 001-40608.

What is the IRS Employer Identification Number for Estrella Immunopharma, Inc.?

The IRS Employer Identification Number for Estrella Immunopharma, Inc. is 86-1314502.

What is the business address of Estrella Immunopharma, Inc.?

The business address of Estrella Immunopharma, Inc. is 5858 Horton Street, Suite 370, Emeryville, CA 94608.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on February 20, 2025 regarding Estrella Immunopharma, Inc. (ESLAW).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing